Filing Details
- Accession Number:
- 0001493152-22-025978
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-15 16:05:36
- Reporting Period:
- 2022-09-14
- Accepted Time:
- 2022-09-15 16:05:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1359931 | Protara Therapeutics Inc. | TARA | Biological Products, (No Disgnostic Substances) (2836) | 204580525 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1595855 | Opaleye Management Inc. | One Boston Place, 26Th Floor Boston MA 02108 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-09-14 | 14,100 | $3.98 | 2,570,777 | No | 4 | P | Indirect | By Opaleye, L.P. |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-09-14 | 2,500 | $3.98 | 130,000 | No | 4 | P | Indirect | By Managed Account |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-09-15 | 5,000 | $3.80 | 2,575,777 | No | 4 | P | Indirect | By Opaleye, L.P. |
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-09-15 | 2,300 | $3.80 | 132,300 | No | 4 | P | Indirect | By Managed Account |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Opaleye, L.P. |
No | 4 | P | Indirect | By Managed Account |
No | 4 | P | Indirect | By Opaleye, L.P. |
No | 4 | P | Indirect | By Managed Account |
Footnotes
- Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.